Literature DB >> 15738878

[Recommendations for the diagnostic and therapeutic management of basal cell carcinoma in adults].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15738878     DOI： 10.1016/s0242-6498(04)94008-4

Source DB:  PubMed          Journal:  Ann Pathol        ISSN： 0242-6498            Impact factor:   0.407


× No keyword cloud information.
  1 in total

1.  Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma.

Authors:  Nicolas Bertrand; Pierre Guerreschi; Nicole Basset-Seguin; Philippe Saiag; Alain Dupuy; Sophie Dalac-Rat; Véronique Dziwniel; César Depoortère; Alain Duhamel; Laurent Mortier
Journal:  EClinicalMedicine       Date:  2021-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.